Skip to main content
AZTA logo

AZTA · Azenta, Inc. · Earnings Call Transcripts & Audio

Track AZTA — free
$34.80 -0.09 (-0.26%)
Market Cap
$1.50B
Shares
43.81M
Volume · Oct 1 177.73K Avg daily vol (3M) 743.02K

Azenta, Inc. Earnings Call Transcripts

Quarterly earnings calls for Azenta, Inc. (AZTA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q3
2026-08-05
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Positive tone Multi-omics turnaround Regional performance — China and Europe Fiscal 2026 outlook and Q4 guidance
Revenue
$161.18M
▲ 12% YoY
Diluted EPS
$0.05
Gross margin
44.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-05-06
Azenta, Inc. (AZTA) Q2 2026 Earnings Call Transcript
Cautious tone Multiomics transformation under new leadership Gene synthesis and next-gen sequencing strategy Revised FY2026 outlook
Revenue
$144.79M
▲ 1% YoY
Diluted EPS
$-3.49
Gross margin
42.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-03-03
Azenta, Inc. (AZTA) March 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-02-04
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
Positive tone Turnaround execution and operational excellence Margin expansion and cost actions Sample management and biorepositories
Revenue
$148.64M
▲ 0.8% YoY
Diluted EPS
$-0.34
Gross margin
42.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-21
Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript
Confident tone Capital deployment priorities: M&A focus areas Capital allocation and balance sheet flexibility Fiscal 2025 financial results and margin expansion
Revenue
$159.19M
▲ 5.7% YoY
Diluted EPS
$1.11
Gross margin
45.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-05
Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript
Positive tone Growth priorities and innovation Operational turnaround and cost discipline Next-gen sequencing and core lab strength
Revenue
$143.85M
▼ 0.3% YoY
Diluted EPS
$-1.05
Gross margin
46.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-07
Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript
Positive tone Multiomics and Next Gen Sequencing Organic Growth and Financial Performance Macro Uncertainty and Tariffs
Revenue
$143.34M
▲ 5.1% YoY
Diluted EPS
$-1.04
Gross margin
43.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-02-05
Azenta, Inc. (AZTA) Q1 2025 Earnings Call Transcript
Positive tone Multiomics business (NGS, Sanger, ONT) Gene Synthesis positioning and capacity Full-year 2025 guidance reiteration
Revenue
$147.44M
▲ 3.7% YoY
Diluted EPS
$-0.25
Gross margin
46.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-11-12
Azenta, Inc. (AZTA) Q4 2024 Earnings Call Transcript
Positive tone Multiomics growth and pricing Ascend 2026 and margin expansion Sample Management Solutions and automation
Revenue
$150.60M
▲ 156.3% YoY
Diluted EPS
$-0.14
Gross margin
45.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-08-06
Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript
Confident tone Multiomics / NGS (Next-Generation Sequencing) business Ascend 2026 profitability and cost transformation program Quarterly financial performance and organic growth
Revenue
$144.29M
▼ 13% YoY
Diluted EPS
$-0.12
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-08
Azenta, Inc. (AZTA) Q2 2024 Earnings Call Transcript
Positive tone B Medical Sciences and vaccine cold chain Multiomics and Next Generation Sequencing China outperformance
Revenue
$136.35M
▼ 8.1% YoY
Diluted EPS
$-2.48
Gross margin
43.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-02-07
Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript
Positive tone FY2024 guidance and B Medical ramp Q1 results and organic revenue decline Multiomics and next-generation sequencing
Revenue
$142.20M
▼ 20.3% YoY
Diluted EPS
$-0.25
Gross margin
43.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-11-13
Azenta, Inc. (AZTA) Q4 2023 Earnings Call Transcript
Revenue
$58.77M*
▼ 57.3% YoY
Gross margin
75.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-08
Azenta, Inc. (AZTA) Q3 2023 Earnings Call Transcript
Revenue
$165.95M
▲ 25% YoY
Diluted EPS
$-0.02
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-05-09
Azenta, Inc. (AZTA) Q2 2023 Earnings Call Transcript
Revenue
$148.40M
▲ 2% YoY
Diluted EPS
$-0.07
▼ 100.2% YoY
Gross margin
35.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-02-08
Azenta, Inc. (AZTA) Q1 2023 Earnings Call Transcript
Revenue
$178.37M
▲ 27.7% YoY
Diluted EPS
$-0.15
▼ 125.9% YoY
Gross margin
41.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-11-14
Azenta, Inc. (AZTA) Q4 2022 Earnings Call Transcript
Revenue
$137.57M*
▲ 0.5% YoY
Gross margin
42.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-07-13
Azenta, Inc. (AZTA) Q3 2022 Earnings Call Transcript
Revenue
$132.74M
▲ 2.8% YoY
Diluted EPS
$-0.13
▼ 124.5% YoY
Gross margin
44.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-05-09
Azenta, Inc. (AZTA) Q2 2022 Earnings Call Transcript
Revenue
$145.54M
▲ 12.4% YoY
Diluted EPS
$28.28
▲ 8737.5% YoY
Gross margin
48.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-02-08
Azenta, Inc. (AZTA) Q1 2022 Earnings Call Transcript
Revenue
$139.65M
▲ 18.2% YoY
Diluted EPS
$0.58
▲ 65.7% YoY
Gross margin
48.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-11-10
Azenta, Inc. (AZTA) Q4 2021 Earnings Call Transcript
Revenue
$136.94M
▲ 26.5% YoY
Diluted EPS
$0.29
▼ 25.6% YoY
Gross margin
48.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-08-05
Azenta, Inc. (AZTA) Q3 2021 Earnings Call Transcript
Revenue
$129.09M
▲ 38.4% YoY
Diluted EPS
$0.53
▲ 178.9% YoY
Gross margin
48.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-05-10
Azenta, Inc. (AZTA) Q2 2021 Earnings Call Transcript
Revenue
$129.53M
▲ 35.9% YoY
Diluted EPS
$0.32
▲ 166.7% YoY
Gross margin
44.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-02-02
Azenta, Inc. (AZTA) Q1 2021 Earnings Call Transcript
Revenue
$118.14M
▲ 28.9% YoY
Diluted EPS
$0.35
▲ 94.4% YoY
Gross margin
48.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-11-10
Azenta, Inc. (AZTA) Q4 2020 Earnings Call Transcript
Revenue
$108.25M
Diluted EPS
$0.39
Gross margin
48.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-07-30
Azenta, Inc. (AZTA) Q3 2020 Earnings Call Transcript
Revenue
$93.30M
▼ 54.2% YoY
Diluted EPS
$0.19
▲ 90% YoY
Gross margin
42.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-04-13
Azenta, Inc. (AZTA) Q2 2020 Earnings Call Transcript
Revenue
$95.30M
▼ 52% YoY
Diluted EPS
$0.12
▲ 140% YoY
Gross margin
43.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-02-06
Azenta, Inc. (AZTA) Q1 2020 Earnings Call Transcript
Revenue
$91.69M
▼ 48.9% YoY
Diluted EPS
$0.18
▼ 10% YoY
Gross margin
42.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–28 of 28 earnings calls
Key facts CIK 933974 CUSIP 114340102 13F (30d) 8 filings 8 filers Visit website Investor relations